2009•Chinese Journal of Hospital PharmacyRequires access

Study on pharmacokinetics and bioavailability of nirendipine crystal polymorphs in rabbits

Lou Jian-shi

Open publisher page 1 citations

Abstract

OBJECTIVE To study the pharmacokinetics and relative bioavailability of nitrendipine crystal polymorphs in rabbits.METHODS According to the Latin's design,6 rabbits were divided into 3 groups with cross-over design of oral nitrendipine administration I,II and Ⅲ capsules 80 mg·kg-1 respectively.The plasma concentrations were determined by HPLC.The pharmacokinetic parameters were calculated.RESULTS After a single oral dose,the peak plasma concentration(Cmax)of nitrendipine Ⅰ,Ⅱ and Ⅲ were(351.5±18.7),(392.7±50.8),(822.1±39.7)μg·L-1;the peak time(tmax)were(1.72±0.16),(1.83±0.11),(1.81±0.18)h;the half-time(t1/2)were(13.3±3.5),(8.6±1.2),(8.0±2)h;the area under curve(AUC0→t)were(3 635.1±230.8),(2 697.0±209.4),(6 428.6±585.6)h·μg·L-1,respectively.The relative bioavailability of nitrendipine Ⅱ,Ⅲ to nitrendipine Ⅰ were 62.1% and 169.0%.CONCLUSION There was no bioequivalence among nitrendipine polymorphs.

About this research paper

What this paper is about

OBJECTIVE To study the pharmacokinetics and relative bioavailability of nitrendipine crystal polymorphs in rabbits.METHODS According to the Latin's design,6 rabbits were divided into 3 groups with cross-over design of oral nitrendipine administration I,II and Ⅲ capsules 80 mg·kg-1 respectively.The plasma concentrations were determined by HPLC.The pharmacokinetic parameters were calculated.RESULTS After a single oral dose,the peak plasma concentration(Cmax)of nitrendipine Ⅰ,Ⅱ and Ⅲ were(351.5±18.7),(392.7±50.8),(822.1±39.7)μg·L-1;the peak time(tmax)were(1.72±0.16),(1.83±0.11),(1.81±0.18)h;the half-time(t1/2)were(13.3±3.5),(8.6±1.2),(8.0±2)h;the area under curve(AUC0→t)were(3 635.1±230.8),(2 697.0±209.4),(6 428.6±585.6)h·μg·L-1,respectively.The relative bioavailability of nitrendipine Ⅱ,Ⅲ to nitrendipine Ⅰ were 62.1% and 169.0%.CONCLUSION There was no bioequivalence among nitrendipine polymorphs.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the pharmacokinetics and relative bioavailability of nitrendipine crystal polymorphs in rabbits.METHODS According to the Latin's design,6 rabbits were divided into 3 groups with cross-over design of oral nitrendipine administration I,II and Ⅲ capsules 80 mg·kg-1 respectively.The plasma concentrations were determined by HPLC.The pharmacokinetic parameters were calculated.RESULTS After a single oral dose,the peak plasma concentration(Cmax)of nitrendipine Ⅰ,Ⅱ and Ⅲ were(351.5±18.7),(392.7±50.8),(822.1±39.7)μg·L-1;the peak time(tmax)were(1.72±0.16),(1.83±0.11),(1.81±0.18)h;the half-time(t1/2)were(13.3±3.5),(8.6±1.2),(8.0±2)h;the area under curve(AUC0→t)were(3 635.1±230.8),(2 697.0±209.4),(6 428.6±585.6)h·μg·L-1,respectively.The relative bioavailability of nitrendipine Ⅱ,Ⅲ to nitrendipine Ⅰ were 62.1% and 169.0%.CONCLUSION There was no bioequivalence among nitrendipine polymorphs.

Key concepts: Nitrendipine, Bioavailability, Pharmacokinetics, Bioequivalence, Cmax, Pharmacology, Chemistry, Oral administration

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on pharmacokinetics and bioavailability of nirendipine crystal polymorphs in rabbits — Research Paper | ScholarLens